Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atopic Dermatitis (AD)”

226 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 226 results

Early research (Phase 1)Study completedNCT07466940
What this trial is testing

A Clinical Study to Evaluate SM17 in Healthy Participants

Who this might be right for
Atopic DermatitisAsthmaInflammatory Bowel Disease
SinoMab BioScience Ltd 30
Not applicableActive Not RecruitingNCT05669794
What this trial is testing

An Observational Study to Assess Change in Disease Activity and Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in Real World

Who this might be right for
Atopic Dermatitis
AbbVie 300
Large-scale testing (Phase 3)WithdrawnNCT04666675
What this trial is testing

Oral Upadacitinib Tablets to Assess Change in Disease State in Participants Aged 12-75 Years With Moderate to Severe Atopic Dermatitis in Brazil

Who this might be right for
Atopic Dermatitis (AD)
AbbVie
Testing effectiveness (Phase 2)Looking for participantsNCT06524635
What this trial is testing

Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab

Who this might be right for
Hidradenitis SuppurativaAtopic Dermatitis
AbbVie 60
Testing effectiveness (Phase 2)Study completedNCT06923228
What this trial is testing

Assess Efficacy and Safety of CGB-500, 1% Tofacitinib Versus an Active Comparator for Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
CAGE Bio Inc. 3
Testing effectiveness (Phase 2)Ended earlyNCT04220411
What this trial is testing

AR100DP1 in Mild to Moderate Atopic Dermatitis (AD)

Who this might be right for
Dermatitis, Atopic
Arjil Pharmaceuticals LLC 17
Early research (Phase 1)Ended earlyNCT07146971
What this trial is testing

Clinical Evaluation of Skin Microbiome an Over-The-Counter (OTC) Drug for Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Good Molecules, LLC 3
Large-scale testing (Phase 3)Study completedNCT05375929
What this trial is testing

Learn About Abrocitinib Tablets in People With Atopic Dermatitis in India

Who this might be right for
Atopic Dermatitis
Pfizer 200
Testing effectiveness (Phase 2)Looking for participantsNCT07230483
What this trial is testing

A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.

Who this might be right for
Atopic Dermatitis (AD)
Keymed Biosciences Co.Ltd 246
Not applicableActive Not RecruitingNCT05387980
What this trial is testing

Learn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis.

Who this might be right for
Atopic Dermatitis
Pfizer 1,128
Not applicableLooking for participantsNCT07316465
What this trial is testing

Birth Cohort: Development of IgE Autoantibodies in Newborns With (High Risk of) Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)AutoantibodyAuto-Immunity+4 more
Universitair Ziekenhuis Brussel 500
Early research (Phase 1)Study completedNCT07329101
What this trial is testing

Clinical Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VC005 in Adolescent Subjects With Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Jiangsu vcare pharmaceutical technology co., LTD 11
Post-approval studies (Phase 4)Ended earlyNCT03539601
What this trial is testing

Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate AD

Who this might be right for
Atopic Dermatitis
Pfizer 237
Testing effectiveness (Phase 2)UnknownNCT04725136
What this trial is testing

Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj. for Moderate to Severe Chronic Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Kang Stem Biotech Co., Ltd. 96
Large-scale testing (Phase 3)Study completedNCT05667623
What this trial is testing

To Demonstrate the Superiority of IMP (1% OPA-15406 Ointment) to the Vehicle in Adult Patients With AD

Who this might be right for
Atopic Dermatitis (AD)
Otsuka Beijing Research Institute 270
Large-scale testing (Phase 3)Study completedNCT03346434
What this trial is testing

Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to <6 Years With Moderate-to-Severe Atopic Dermatitis (Liberty AD PRESCHOOL)

Who this might be right for
Dermatitis, Atopic
Regeneron Pharmaceuticals 202
Large-scale testing (Phase 3)Study completedNCT05704738
What this trial is testing

Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Amgen 532
Not applicableStudy completedNCT05682976
What this trial is testing

Ophthalmological Adverse Events of Tralokinumab in AD

Who this might be right for
Atopic Dermatitis
Nantes University Hospital 100
Testing effectiveness (Phase 2)Study completedNCT02925793
What this trial is testing

Safety and Efficacy Study of Topically Applied DS107 Cream in Mild to Moderate Atopic Dermatitis Patients (AD)

Who this might be right for
Atopic Dermatitis
DS Biopharma 327
Testing effectiveness (Phase 2)Study completedNCT07186387
What this trial is testing

Study of LW402 in Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Shanghai Longwood Biopharmaceuticals Co., Ltd. 144
Load More Results